Literature DB >> 8545090

Oscillatory potentials in subjects with treated hypertension.

G Ravalico1, G Rinaldi, N Solimano, G Bellini, A Cosenzi, A Sacerdote, E Bocin.   

Abstract

Oscillatory potentials of the ERG proved to be a sensitive indicator even in mild disturbances of retinal circulation, such as the first stage of hypertensive retinopathy (WHO classification). Oscillatory indexes (OIs) and blood pressure levels of 24 hypertensive patients in stage 1 of the WHO classification, who underwent an antihypertensive therapy for the first time, were considered. The patients were retested after a mean period 8 months. a strict inverse correlation was found between OIs and blood pressure levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545090     DOI: 10.1159/000310610

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  5 in total

1.  Extraction and modelling of oscillatory potentials.

Authors:  Bang Viet Bui; James Andrew Armitage; Algis Jonas Vingrys
Journal:  Doc Ophthalmol       Date:  2002-01       Impact factor: 2.379

2.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

3.  Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice.

Authors:  Shuai Wang; Jing Li; Tong Wang; Jie Bai; Yun-Long Zhang; Qiu-Yue Lin; Jing-Min Li; Qi Zhao; Shu-Bin Guo; Hui-Hua Li
Journal:  Mol Ther       Date:  2019-10-05       Impact factor: 11.454

4.  Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy.

Authors:  Birthe Meyer-Rüsenberg; Mitrofanis Pavlidis; Tobias Stupp; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535

5.  Electrophysiological function of the retina and optic nerve in patients with atrial fibrillation.

Authors:  Michal Post; Wojciech Goslawski; Monika Modrzejewska; Maciej Wielusinski; Jaroslaw Kazmierczak; Wojciech Lubinski
Journal:  Doc Ophthalmol       Date:  2015-04-25       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.